Compare Enact Holdings Inc (ACT) vs Herbalife Nutrition Ltd (HLF) Price & Performance

ACT trades at $45.69, up 0.77% today, with a bullish technical signal and strong moving averages. The stock shows robust fundamentals with a net income margin of 54.49% and a P/E ratio of 9.89. Recent news includes a 14% dividend increase announced on May 5, 2026, and Q1 2026 earnings that met expectations. Analyst consensus is a $47.50 price target with a mix of buy and hold ratings.

Outlook remains positive due to high profitability and dividend growth, but risks include earnings volatility and market sensitivity. Upside is supported by institutional sentiment and consistent cash flow, though investors should monitor execution against future earnings estimates.

Herbalife (HLF) trades at $13.14, showing modest daily gains of 0.23%. The stock presents a mixed technical picture with neutral signals from oscillators and bearish moving averages. Fundamentally, HLF maintains strong gross margins of 77.78% and attractive valuation metrics including a P/E of 5.64 and P/S of 0.26. Recent Q1 2026 earnings beat expectations with $0.64 EPS versus $0.607 expected, while the company completed a significant $1.45 billion debt refinancing in April 2026 to strengthen its balance sheet.

HLF offers value investment appeal with deep discount valuations and improving debt trends, though negative shareholder equity and competitive pressures in the nutrition space present ongoing challenges. Analyst sentiment leans bullish with 57.7% buy ratings, but the stock faces headwinds from its multi-level marketing model scrutiny and regional market volatility. The upcoming Q2 2026 earnings on August 5 will be crucial for validating recent guidance increases.